| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_18d938aa1b75b88f5a116a30536dc97b |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01L2300-0645
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01L2400-0439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01L2200-0652 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12M41-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01L3-502776
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01L3-502761
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12M33-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12M35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12M29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12M35-02 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12M1-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01L3-00 |
| filingDate |
2020-11-20^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc68225d5ca580261c9ad1578b9ed94d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ce53603b0f1ddc9eac6ad8ecb6d4ccd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a6aa1575500be99ea2ee24e963f046fd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41b1e1c19cabb9dbf3a731b03b099b6d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_85672a74590506078a09a83c80131ca5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dbf863541d51b62c6b576ed6f2c5a40f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5312cd5be4df98f8eef70f3b69b027c0 |
| publicationDate |
2022-11-29^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-115413295-A |
| titleOfInvention |
Systems for Electroporation of Particles |
| abstract |
Systems for cell bioprocessing and cell therapy manufacturing can include a series of microfluidic modules to enable continuous flow end-to-end cell bioprocessing. Each module can implement a different technology, and the modules can be coupled to each other to perform various unit operations in the cell bioprocessing or cell therapy manufacturing chain, enabling direct processing of blood or blood product samples. The system can automatically and continuously process samples into genetically modified lymphocytes or T cells for cell therapy. The techniques implemented by each module in the system can include any combination of microfluidic acoustophoresis, microfluidic acoustophoresis medium exchange or cell washing, and continuous flow microfluidic electrotransfection. The modules implementing these microfluidics can be interconnected with plastic tubes or custom manifolds. |
| priorityDate |
2019-11-22^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |